A detailed history of Fmr LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Fmr LLC holds 8,065,677 shares of PRTA stock, worth $173 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,065,677
Previous 8,006,411 0.74%
Holding current value
$173 Million
Previous $198 Million 16.06%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$19.54 - $26.15 $1.16 Million - $1.55 Million
59,266 Added 0.74%
8,065,677 $166 Million
Q1 2024

May 13, 2024

SELL
$24.75 - $40.66 $1.07 Million - $1.76 Million
-43,385 Reduced 0.54%
8,006,411 $198 Million
Q4 2023

Feb 13, 2024

BUY
$32.31 - $52.32 $630,238 - $1.02 Million
19,506 Added 0.24%
8,049,796 $293 Million
Q3 2023

Nov 13, 2023

BUY
$47.3 - $70.6 $5.56 Million - $8.3 Million
117,524 Added 1.49%
8,030,290 $387 Million
Q2 2023

Aug 11, 2023

BUY
$48.26 - $78.59 $55.5 Million - $90.4 Million
1,150,741 Added 17.02%
7,912,766 $540 Million
Q1 2023

May 11, 2023

BUY
$46.97 - $58.27 $132 Million - $164 Million
2,814,753 Added 71.31%
6,762,025 $328 Million
Q4 2022

Feb 13, 2023

BUY
$52.05 - $65.0 $40.9 Million - $51 Million
784,854 Added 24.82%
3,947,272 $238 Million
Q3 2022

Nov 10, 2022

BUY
$25.16 - $60.63 $5.96 Million - $14.4 Million
237,020 Added 8.1%
3,162,418 $192 Million
Q2 2022

Aug 12, 2022

BUY
$22.73 - $39.98 $5.68 Million - $9.99 Million
249,784 Added 9.34%
2,925,398 $79.4 Million
Q1 2022

May 13, 2022

BUY
$30.27 - $49.22 $1.03 Million - $1.67 Million
33,873 Added 1.28%
2,675,614 $97.8 Million
Q4 2021

Feb 14, 2022

SELL
$42.11 - $73.26 $323,825 - $563,369
-7,690 Reduced 0.29%
2,641,741 $131 Million
Q3 2021

Nov 15, 2021

SELL
$48.2 - $78.89 $6.21 Million - $10.2 Million
-128,856 Reduced 4.64%
2,649,431 $189 Million
Q2 2021

Aug 13, 2021

BUY
$21.63 - $57.65 $60.1 Million - $160 Million
2,778,287 New
2,778,287 $143 Million

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $1.01B
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.